Martin-Albright Pseudohypoparathyroid Syndrome

Martin-Albright Pseudohypoparathyroid Syndrome (MPS) is a rare autoimmune disease that is characterized by the production of antibodies against parathyroid hormone (PTH), which leads to low blood calcium levels and dysfunction of the parathyroid glands.

This condition was first described in 1948 by Swiss physician Eva Martin and American physician Frederick Albright. Since then, many researchers have studied this disease and found that it can be caused by various factors, such as genetic mutations, infections, injuries and other diseases.

MPS can present with a variety of symptoms, including osteoporosis, muscle weakness, bone and joint pain, and kidney and heart problems. In severe cases, bone fractures and tooth loss may occur.

To diagnose MPS, a blood test for calcium and PTH levels, as well as other tests, is used. Treatment depends on the severity of the disease and may include calcium supplements, vitamin D, and other medications.

Thus, MPS is a serious disease that requires timely diagnosis and treatment. It is important to understand that this condition can be caused by various factors, so you should consult a doctor when the first symptoms appear.